Igor F. Palacios, MD Lectureship and Symposium

Saturday, October 1, 2022 | Hybrid (Live & Virtual) Symposium
Aortic Valve Disease , Advanced Structural Heart Disease Interventions, Complex Coronary Artery Disease Update, & Complex Structural Case Presentations

Case Presentations & Live Panel Discussions

This one-day symposium will use case-based discussions to promote the understanding of recent technologies for the treatment of mitral, tricuspid, or aortic valve disease. The program will highlight patients’ characteristics that qualify them to benefit from these technologies.

Please note masks will be enforced.

 

Agenda

Morning Session 

7:00 – 7:50  Exhibits

7:50 – 7:55  Welcome and Opening Remarks | Guilherme Silva, MD | Baylor College of Medicine and Texas Heart Institute

Igor F. Palacios Lectureship Structural Keynote Speaker

8:00 – 8:30  Updates in TMVR | Mayra Guerrero, MD | Mayo Clinic

Aortic Valve Disease

Panelists: Drs. Howard Herman, Hani Jneid, Joseph Coselli, Adam Saltzman, Palacios, Llanos, Silva

8:35 – 8:50  Considerations Relative to TAVR and SAVR with a Small Aortic Annulus | Howard Herrmann, MD | Hospital of the University of Pennsylvania, Perelman School of Medicine

8:55 – 9:10  Tuning Patients Up for TAVR | Gaston Cudemus, MD | NCH Heart Institute

9:15 – 9:30  Special Considerations in Our Frail TAVR Patients | Andrew Rassi, MD | Kaiser Permanente San Francisco Medical Center

9:35 – 9:50  Role of the Heart Team in 2022 | Jonathan Passeri, MD | Massachusetts General Hospital

9:55 – 10:15  Panel Discussion and Q & A 

Advanced Structural Heart Disease Interventions

Panelists: Drs. Suzanne Baron, Jose Condado, Stephanie Coulter, Ignacio Inglessis, Palacios, Llanos, Silva

10:20 –10:35  Pulmonic Valve Replacement | Ignacio Inglessis, MD | Massachusetts General Hospital

10:40 – 10:55  Imaging for Mitral Valve interventions | Mayra Guerrero, MD | Mayo Clinic

11:00 – 11:15  LAAO Updates/Tips and Tricks | Ignacio Cruz Gonzalez, MD | Universidad de Salamanca

11:20 – 11:40  Panel Discussion and Q & A 

11:45 – 12:45  Lunch and Exhibits 

Afternoon Session 

Complex Coronary Artery Disease Update

Panelists: Drs. Angel Caldera, Roberto Cubeddu, Rodrigo Do Lago, Christian Witzke, Palacios, Llanos, Silva

12:50 – 1:05  Hybrid Coronary Revascularization with Valvular Heart Disease | Pedro Moreno, MD | Mount Sinai Hospital

1:10 – 1:25  Updates in Chronic Total Occlusion (Case/Data) | Farouc Jaffer, MD | Massachusetts General Hospital

1:30 – 1:40  Percutaneous Tricuspid Valve Repair | Robert Cubeddu, MD | NCH Heart Institute

1:45 – 1:55  The Use of Balloon Mediated Intravascular Lithotripsy (shockwave) for Optimization of Transfemoral TAVR Access (Case/Data) | Rodrigo Lo Lago, MD | Advent Health Medical Group

1:55 – 2:05  Panel Discussion and Q & A

Complex Structural Case Presentations

Panelists: Drs. Srikanth Koneru, Mayra Guerrero, Ethan Korngold, Pedro Moreno, Nicholas Ruggiero, Palacios, Llanos, Silva

2:05 – 2:20  VSD Case | Pablo Rengifo-Moreno, MD | Tallahassee Memorial Healthcare

2:25 – 2:40  Complex MitraClip/Complication | Christian Witzke, MD | Einstein Medical Center Philadelphia, Thomas Jefferson University Hospital

2:45 – 3:00  Impella Unloading for Anterior MI | Carlos Davila, MD | Yale Health – Yale School of Medicine

3:05 – 3:20  Electrosurgery for Mitral Valve Modification: Lampoon | Jose Condado Contreras, MD | Baylor Scott & White Clinic

3:25 – 3:40  Percutaneous Tricuspid Regurgitation Replacement | Sammy Elmariah, MD | University of California San Francisco

3:45 – 4:00  Mitral/Tricuspid Regurgitation Complex Case | Dabit Arzamendi, MD | Hospital De La Santa Creu i Sant Pau

4:05 – 4:20  TAVR and Thrombosis (Case/Data) | Angel Caldera, MD | Texas A&M Health Science Center and Baylor Scott & White Health Care

4:30 pm  Closing Remarks | Igor Palacios, MD – Massachusetts General Hospital | Alex Llanos, MD – Holy Cross Health | Guilherme Silva, MD – Baylor College of Medicine and Texas Heart Institute

Program Overview

This one-day symposium will use case-based discussions to promote the understanding of recent technologies for the treatment of mitral, tricuspid, or aortic valve disease. The program will highlight patients’ characteristics that qualify them to benefit from these technologies.

Please note masks will be enforced.

Target Audience

The target audience includes physicians, physician assistants, nurse practitioners, registered nurses, medical students and other medical care providers who are interested in this medical care.

Educational Objectives

At the conclusion of this symposium, participants should be able to

• Discuss the mechanisms by which mitral clip and TAVR valves improve maladies of mitral, tricuspid, and aortic valves

• Discuss how to recognize potential benefiting patients for the new technologies

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Texas Heart Institute and Baylor College of Medicine. Texas Heart Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 8.50 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Registration

$50 Physicians ( LIVE )

$0.00 Residents, Fellows (LIVE)

$0.00 Non-Physician (PA, NP, Nurses, Medical Students)  (LIVE)

$25 Physicians (VIRTUAL)

$0.00 Residents, Fellows (VIRTUAL)

$0.00 Non-Physician (PA, NP, Nurses, Medical Students)  (VIRTUAL)